We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
If you can't make Thursday's AGM and have a question you want put forward on an anonymous basis and don't have time to contact Valirx for answers. I as still happy to add to the submission list being sent late tonight ie. being submitted after 10pm Tuesday 28th
Please reply to this thread
I have some additional questions messaged to me and an interesting one apparently from the old guard via ADVFN should be a comprehensive presentation on Thursday
GLA
@viera
Thanks Nick, mutual respect, appreciated
@Iceman888
Fair enough, the business is far far bigger than the sum of one small shareholder shocked that some even think I have any influence over what this business does
@SouthernInvestor
Look all I simply want to do here Is try and ensure that all concerns are at least sent to the business. If they answer or not is another matter
GLA
Thanks Porky for collating all the questions.
You’re a good bloke
@rhubarbmk2
Perfect, glad you can be in London to fight SH corner, brilliant
@sharedealer123
Question Added
Brilliant that rhubarb2. I can’t help but think when all the questions raised are answered , and a fund raise is authorised to go through val will be in a much stronger position. To have the company financially stable for the foreseeable future will bring so much confidence. It’s then up to Suzy and the board to build on this. As I have said in earlier posts if they aren’t going to come up with the finance then bin bag them it’s as simple as that. We needs to go forward not stagnate. I’ve noted that yes it’s hard at the moment to raise funds , but if they can’t do it let’s deal with someone who can. Goood luck to all let’s hope we get some good positive news this week, and the company moves forward.
Very happy for Porky's collation. I plan to attend and vote in person, so if anything isn't covered, I will try and ask to fill any gaps.
I agree with OB here porky, good set of extensive questions being posed. Watch out for the brigade of unsettled posters this week, actually think they have arrived already, obviously have ulterior motives and you can see right through them! All eyes on VAL this week, come on suze let’s get some news out that we have been waiting for. ATB :)
Do the BOD like steak & ale pie or pork pies
@OB
Thanks
I just think its better that questions are asked and put forward than not at all. I agree that Adam would make a fantastic spokesman and far far far better than I but, we don't know what time he has available he might not have time to take it on. At least i'm trying to do something than nothing being said.
I would also point out that unfortunately for me, i am not is a position to take advantage of any possible placing if they do proceed with one. I do not have sufficient liquidity until late August as such i wont benefit if its called next week and will be buying in open market at a later time. So i have no hidden agenda.
I do however, have a vested interest in this stock doing well. last thing i need is another bio like 4D in my portfolio going south so in that regard yes, indirectly i would benefit if the result from next weeks AGM is positive.
IF they present well next week and cover off all concerns the outcome could well be real positive and attract more investor support. You never know. Could be good for the stock.
Recent events at 4D, SNG, AVCT etc will deffo cast shadows over this sector so the positive the better
GLA
Porky
You are more than aware that some folks here find you as popular as a bacon sandwich at a vegan festival.
However I know you’re about as thick skinned as they come..
As far as I am concerned they are very good questions, I’m not going to, lie I would have preferred if the likes of Adam had been our spokesperson, however I welcome you collating and emailing them ..
So I will be unpopular and say thanks …
We are all obviously aware you are not doing it for us mind ;) lol
OB
c) Can you seek any external support/ promotion. Perhaps considering engaging a sponsor or patron or spokesperson with a specific condition that the pipeline drug is trying to cure/improve? This could also highlight the work of Valirx, update on the drugs journey on an ongoing basis but more important help raise awareness of Valirx which could in turn help you secure more investor support.
END
As i say, i DO NOT wish to represent anyone or anything. Simply happy to collate and send. IF SH have concerns better that the business knows about them than remain in the dark imo. Any questions added to this thread will be sent on an anonymous basis. No guarantees the Question's will be answered.
11. There is an SH concern that they don't trust the current board in terms of fighting for shareholder interests. Can you provide any reassurances that you are trying to drive the SP higher? One option would be setting Share Options or awards only when the SP reaches certain milestones which could be set at a higher level than the current SP. In one example perhaps 22p in line with the CENKOS warrant price.
12. A high desire for you to offer Adam Hargreaves a Non-Exec job on your board. We don’t know if he would be in a position to accept but SH feel they want someone on the team acting purely in SH Interests.
Legacy Assets
13. As a general point we feel that you need to tighten up on milestone dates for progress and updating shareholders of same. Nothing worse for investors than being in the dark. Can you consider more regular updates?
14. 201
a) You decided to support a stateside start up SPV to take 201 forwards. Was this the only option? How is this business going to be structured? Is it going to be listed? What will the ownership structure of this business look like?
b) We understand that despite the service agreement being signed 1/11/21 the 10k per month payment has not been received. Are they likely to pay it? Why did you agree to do all the support work to date Free of Charge?
c) Can you confirm now EXACTLY how much TRx are raising? Can you be sure that on reaching future milestones they will pay you and we won’t be in a similar fund-raising debacle?
d) We appreciate that Due Diligence takes time, but you are granting yet a further extension, is there a point where you will have to say enough is enough and go back to square one and seek a new partner for 201. Will there be a point where exclusivity for TRx will be lost?
15. 301
a) Is it time now to move this from the Japan partner and either look for a with a new partner to advance this or shelve the asset if can’t be advanced for what ever reason? We accept that not all pipeline assets will succeed are we flogging a dead horse here or do you genuinely see a positive outcome? Numerous concerns regarding lack of clarity on progress. SH feeling of being left in the dark for excessive periods. Some reporting milestones are essential here.
16. 401
a) What is going on with 401. It’s been at the end of phase 2 for what feels like an eternity. Is there any progress on this drug?
17. BC201 for sepsis
a) Will this move to Phase 1 or at least to point of being fully optimised? What timeline do you have to get to the fully optimisation point? How active are the partners on this?
18. New Assets
a) The Triple we await the update on, but can you also add to the pipeline the other assets that are also under evaluation?
b) Will you be able to add more new pipeline assets to advance? It would be good to see at least 4 new pipeline assets added this year. Is that realistic? Possible?
cont...
List so far:-
Resolutions voted
1. SH accept the need for a placing however rather than issue 40m shares now, half commercial half PI would you consider doing this in two smaller tranches? With the second deferred until market conditions improve or is this not possible? Shareholders worry about dilution but equally except conditions are dire.
2. The 6.5m Share Options. Can you confirm that at least some of these will be granted to new board additions made and is it possible that some could also be set as options rather than pure free issue on achieving certain improvements in the future share price. Investors want to feel that the board is fully focused on the SP increasing.
3. If you are proceeding with a placement and CENKOS are going to receive fees as a result can the disastrous previous 22p SH warrant deal with CENKOS be scrapped to avoid even further dilution and blocks of shares being sold by them further down the line.
General
4. You make numerous references to acquiring a lab. Have you a lab in mind? What is the expected outlay for this lab? Will it be funded by debt, or the equity raise or a mixture? What will the ownership structure be, will it be 100% wholly owned by Valirx?
5. You are building a Biotech at the forefront of Women’s Oncology yet only have one female on the board. Are you going to do anything to redress the balance?
6. Kevin Alexander has resigned do you have a replacement NED are you looking for one?
7. Would you consider adding at least two more NEDs in addition to strengthen your advisory panel to bring fresh ideas and help avoid future commercial pitfalls.
8. There is feeling the BOD needs a Contracts Manager or someone with really strong Biotech negotiation skills to join the team. Would you consider this?
9. In addition to your pipeline page on the website can you add a website page with the milestones expected for each quarter going forwards so Investors have some visibility regarding what we may expect updates on? Progress updates on pipeline drugs? Just basic info like trial dates, trial numbers, number hospitals and such like. There is a fear that SH can end up in a position like with 301 where they don’t hear a thing for years at a time. This needs a higher level of sticking to and reporting within specific timelines and milestones.
10. As the company relies upon the ability to issue new shares to remain a going concern, would management consider having a portion of their current salaries in shares to better align their interests with shareholders?
Cont....
Seriously....
Surely it is better for the company to have a list of shareholder concerns than be in the dark???
I currently have 20+ on the list and its growing....
Going to be a very interesting week thats for sure,lets hope we get a super positive presentation and q&a with a vision for the future.
Cant wait for a few surprises.
@pm2022
Added your questions
@nomlungu
Added your question
Will submit question list by close on Tuesday so they have Wednesday to consider. Please send ANY question that concerns you
I will also run question requesting on ADVFN
16. As the company relies upon the ability to issue new shares to remain a going concern, are management prepared to accept a portion of their current salaries in shares to better align their interests with shareholders?
Porky with respect I don't need to know about DDDD products and no doubt you know more. I just spent 2 minutes looking at the financials and I said I would never go near them unless I see clear evidence of funding. Looking at the basics such as revenue, losses and market cap and as the market cap started to drop I could see what was likely as a placing would not support the issues they had for a decent amount of time. No one will keep throwing money at you if they did not think as a business you can survive and Oxford Finance had to do what was on the cards.
A person can do as much research as they like but it doesn't mean they interpret the information correctly.
I suggest the main question you need to focus on with Suzy is whether they plan to provide regular updates for 201 once trials start otherwise 201 deal will start being priced out? Just basic info like trial dates, trial numbers, number hospitals just the standard stuff really. We don't want a situation like 301 where it goes missing for a few years and in this case until trials are completed and I don't trust the current board in terms of fighting for shareholder interests from what I have seen so far so Adam would be a great addition.
Would forum posters be so kind as to reply with any questions they would like to know answers on. If the questions are not put to the business they have no chance of knowing if concerns are fully covered off or not.
@SouthernInvestor
Assuming your point was a non rhetorical question. The business relies on PI support as its yet to secure an II and bulk of SH use the LSE forum. Nothing wrong in referencing posters. As for Placing for Lab, the Lab will add value and we don't know yet until the AGM the terms of the Lab or if it will be part finance. Its a question already on the list.
Based on previous forum discussion i will also add:-
15. There was talk on forums that Adam would make a brilliant NED. Would the board consider approaching Adam for this role?
11. 301
a) Is it time now to move this from the Japan partner and either look for a with a new partner to advance this or shelve the asset if can’t be advanced for what ever reason? We accept that not all pipeline assets will succeed are we flogging a dead horse here or do you genuinely see a positive outcome?
12. 401
a) What is going on with 401. It’s been at the end of phase 2 for what feels like an eternity. Is there any progress on this drug?
13. BC201 for sepsis
a) Will this move to Phase 1 or at least to point of being fully optimised? What timeline do you have to get to the fully optimisation point? How active are the partners on this?
14. New Assets
a) The Triple we await the update on, but can you also add to the pipeline the other assets that are also under evaluation?
b) Will you be able to add more new assets to advance? It would be good to see at least 4 new pipeline assets added this year. Is that realistic?
Await additions
List so far:-
Resolutions voted
1. SH accept the need for a placing however rather than issue 40m shares now, half commercial half PI would you consider doing this in two smaller tranches? With the second deferred until market conditions improve or is this not possible? Shareholders worry about dilution but equally except conditions are dire.
2. The 6.5m Share Options. Can you confirm that at least some of these will be granted to new board additions made and is it possible that some could also be set as options rather than pure free issue on achieving certain improvements in the future share price. Investors want to feel that the board is fully focused on the SP increasing.
General
3. You make numerous references to acquiring a lab. Have you a lab in mind? What is the expected outlay for this lab? Will it be funded by debt, or the equity raise or a mixture? What will the ownership structure be, will it be 100% wholly owned by Valirx?
4. You are building a Biotech at the forefront of Women’s Oncology yet only have one female on the board. Are you going to do anything to redress the balance?
5. Kevin Alexander has resigned do you have a replacement NED are you looking for one?
6. Would you consider adding at least two more NEDs in addition to strengthen your advisory panel to bring fresh ideas and help avoid future commercial pitfalls.
7. There is feeling the BOD needs a Contracts Manager or someone with really strong Biotech negotiation skills to join the team. Would you consider this?
8. In addition to your pipeline page on the website can you add a website page with the milestones expected for each quarter going forwards so Investors have some visibility regarding what we may expect updates on?
Legacy Assets
9. As a general point we feel that you need to tighten up on milestone dates for progress and updating shareholders of same. Nothing worse for investors than being in the dark. Can you consider more regular updates?
10. 201
a) You decided to support a stateside start up SPV to take 201 forwards. Was this the only option? How is this business going to be structured? Is it going to be listed? What will the ownership structure of this business look like?
b) We understand that despite the service agreement being signed 1/11/21 the 10k per month payment has not been received. Are they likely to pay it? Why did you agree to do all the support work to date Free of Charge?
c) Can you confirm now EXACTLY how much TRx are raising? Can you be sure that on reaching future milestones they will pay you and we won’t be in a similar fund-raising debacle?
d) We appreciate that Due Diligence takes time, but you are granting yet a further extension, is there a point where you will have to say enough is enough and go back to square one and seek a new partner for 201. Will there be a point where exclusivity for TRx will be lost?